Locations:
Abu Dhabi|Canada|Florida|London|Nevada|Ohio|
Gray gradientGray gradient
Cleveland Clinic icon
Consult QD logo
Search IconSearch

Cancer

Microscopic image showing adenocarcinoma of Prostate.
September 20, 2022/Cancer

In Search of Improved Risk Modeling for Cribriform, Intraductal Carcinoma of the Prostate

Can genomic classifiers contemporize stratification?

650×450-Lungs
September 13, 2022/Cancer

Non-Small Cell Lung Cancer Trial Underway for Novel Immunotherapy Treatment

Nikolaev Anatoly, MD
September 13, 2022/Cancer

Florida Researcher Targets High-Risk Oral Squamous Cell Carcinoma

Surface Guided Radiation Therapy
September 13, 2022/Cancer

Tattooless Radiation Therapy Benefits More Than Skin Deep

Advertisement

Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy

22-CNR-3245747-CQD-Hero-650×450 aplastic anemia
September 13, 2022/Cancer/Blood Cancers

Clinical and Molecular Determinants of Clonal Evolution in Aplastic Anemia and Paroxysmal Nocturnal Hemoglobinuria

Retrospective study yields clues to understanding risk of secondary myeloid neoplasms

22-CNR-3105958-CQD-SauterHero-650×450
September 6, 2022/Cancer/Research

Optimizing CAR T-Cell and Stem Cell Transplant Treatments

New BMT leadership looks to clinical research and cell therapy production to overcome treatment access limitations

22-CNR-3126458-CQD-Hero-650×450 PET radiotracer
August 31, 2022/Cancer/Research

Investigational PET Imaging Agent Being Explored as a Predictive Biomarker For Response to Standard Chemotherapies

Pilot Study at Cleveland Clinic is Testing Feasibility and Biodistribution

22-CNR-3155332-CQD-Hero-650×450 Dr Adjei
August 30, 2022/Cancer/News & Insight

Taussig Cancer Institute Chair Brings New Vision for Clinical Research

Breaking through barriers in cancer care

22-CNR-3191400-CQD-Hero-650×450
August 22, 2022/Cancer/Research

Distinct PHTS-related Breast Cancer Genomic Characteristics Discovered

Findings support need for personalized disease management

22-CNR-3103108-CQD-Hero-650×450-LRI flip
August 9, 2022/Cancer/Research

Tumors with Specific Genetic Mutations Show Response to Immune Checkpoint Blockade Therapy

Pathogenic POLE/POLD1 mutations lead to improved response to immune checkpoint blockade therapy

BackPage 17 of 140Next

Advertisement

Ad